Segmedica, a division of Research America Inc., and Endo Pharmaceuticals are thrilled to announce their recognition by Quirk’s as finalists for the Health Care / Pharmaceutical Research Project Award.
Segmedica’s Dr. Barbara Haimowitz will be presenting HealthVoiceTM: Digging Deeper Into The Patient – Doctor Dialogue at the Intellus Worldwide Institute, in Boston Setember 27th.
Segmedica (xsperient®) and Research America Inc. Announce Merger of Companies Segmedica, is pleased to announce that as of January 4th
Research America, the parent company of Segmedica, announces recognition from Quirk’s as part of the 22 Top Health Care Research Companies.
Segmedica has been selected to present at the 2021 Food & Nutrition Conference & Expo™ (FNCE®). The presentation, Cart to Counter: Leveraging Personality Data and Technology to Boost the Grocery Experience, is scheduled for Sunday, October 17th at 11:30AM – 12:30PM CT.
Segmedica has be invited to present in an online forum conducted by DTC Perspectives, an expert events and content provider in the field.
Segmedica is presenting a paper, Achieving and Using a Great Segmentation, in the early afternoon of May 12th.
Segmedica to Present at the 2021 Intellus Summit Join Segmedica at the Intellus Summit Virtual Event in April. We will
Segmedica Launches Telepsychiatry in the Age of COVID-19 In this new ConnexionPoints® report, we provide an up-to-date view of telepsychiatry
Segmedica Launches Modeling Consumer Behavior within Healthcare During COVID-19 In this new ConnexionPoints® report, we used qualitative research and psychology
Segmedica Launches JourneySmart™ Segmedica announces the launch of JourneySmart, enhanced patient journeys. We bring a unique perspective and set of
Segmedica Launches RapidConnexion™ Personal Care and Beauty Series These studies are brief but insightful and designed to bring you up
Segmedica Releases Consumer Perceptions of Healthy Foods Segmedica announces the completion of its sixth syndicated COVID-19 study. Consumer beliefs on
Segmedica Releases Consumer Engagement with Alternative Healthcare Services Segmedica announces the completion of a fifth syndicated COVID-19 study. COVID-19 has
Segmedica Completes Navigating COVID-19 Patient Journey Segmedica announced today the completion of a fourth syndicated COVID-19 study. This study is
Segmedica Completes Personal Care and Beauty During COVID-19 Segmedica announced today the completion of a third syndicated COVID-19 study. In
Adherence and Persistence Self-Study Course Segmedica launches a new self-study course on Adherence and Persistence. This course includes a five-module
Segmedica has published a comprehensive ConnexionPoints Adherence and Persistence eHandbook Segmedica announced today the completion of its ConnexionPoints Adherence and
Segmedica Completes Changing Behaviors in the Face of a Global Health Crisis Segmedica announced today the completion of a syndicated
Segmedica Launches RxConnex™ Segmedica announces the launch of RxConnex, a powerful new pharmacy data tool. For more details visit our
Segmedica Launches TripleSmart™ Segmedica announces the launch of TripleSmart™, a whole new way of looking at market segmentation embracing three
Segmedica Launches Upgraded PersonaSmart™ System Segmedica announces the launch of enhanced consumer segmentation scales PersonaSmart™ and PersonaSmart™ Health Based on
Segmedica in Demand for Consulting and Keynotes Our team is frequently called upon to keynote internal company conferences and enter
